An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
Trial details
- Registry ID
- NCT04145531
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)NCT04145531 | Jazz Pharmaceuticals | Phase 2, Phase 3 | Completed | 2022-07-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |